Prefilled syringes (PFSs) have the benefit of precise dosing and easy administration. Prevalence of their use in the market has increased for a number of reasons, as listed in Section II. In 2011, only 14 drugs were provided in prefilled syringes.[105] In 2013, that number had grown to over 60 drugs and vaccines.[106] As of December 2024, Pfizer alone supplies 24 different drugs[107] in prefilled syringes and the total PFS portfolio is likely well over 100.
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.